Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

UnitedHealth Group (NY: UNH )

500.00 +6.82 (+1.38%)
Streaming Delayed Price Updated: 10:37 AM EDT, Apr 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about UnitedHealth Group

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
56 57 Next >
10 Unsurpassed Stocks That Can Make You Richer in 2024
A new year brings new opportunities to grow your wealth on Wall Street. 
Via The Motley Fool
Stock Picks 2024: 7 Trailblazers Using AI to Revolutionize Their Industries
Although AI-related stock picks for 2024 may be centered on tech firms, the innovation itself achieves broad relevance. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Sustainable Investing: 3 ESG Stocks That Are Also Profitable
ESG stocks are growing in popularity with profitable companies such as UnitedHealth, JP Morgan and Tesla being best-in-class candidates. 
Via InvestorPlace
Cigna's Medicare Business Sale: Health Care Service Could Scoop The Business
Cigna Group (NYSE: CI) is reportedly in advanced negotiations to divest its Medicare Advantage division and is presently in discussions to sell it to Health Care Service Corp Inc (NASDAQ: HCSG) for... 
Via Benzinga
Top Stocks, Sectors Loved By Congress Members Who Traded In 2023: Apple, NVIDIA, Microsoft, Ford And More Stocks To Watch In 2024
One of the hottest topics among members of Congress and investors has been the stock and options trading activity by several politicians. 
Via Benzinga
Tech Sell-Off Triggers Market Reset: Value Stocks Reach 7-Month High Versus Growth
U.S. stock market suffered worst start in two decades, tech sell-off led to cautious investor shift to value stocks, notably IUSV & IUSG ETFs + top gainers MRNA, VTRS, TNL, LVS & VAC. 
Via Benzinga
Topics ETFs
Consulting Firm McKinsey Concludes Opioid Litigation Settlement With $78M Agreement
Consulting giant McKinsey & Co, on Friday, agreed to a settlement of $78 million to resolve allegations tied to the opioid epidemic, as disclosed in federal court papers filed in San Francisco.  
Via Benzinga
UnitedHealth's Decision To Sell Its Operations In Brazil To A Private Investor Leads To $7B Charge - What's On The Cards?
UnitedHealth Group Incorporated (NYSE: UNH) disclosed on Friday that it has entered into an  
Via Benzinga
There Are Only 5 Dow Stocks I Wouldn't Buy in 2024
There's a lot to like about Apple, Microsoft, and most of the Dow Jones Industrial Average components in 2024. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
Big Players' Recent Trades in UNH Options
Via Benzinga
Peering Into UnitedHealth Group's Recent Short Interest
Via Benzinga
UNH Stock Alert: What to Know as UnitedHealth Agrees to Sell Brazil Operations
UnitedHealth remains the dominant force in the U.S. health insurance system. Here's what to know about UNH stock today. 
Via InvestorPlace
3 Stocks to Buy Now Before They Become Tomorrow’s Trillion-Dollar Companies
These future trillion dollar stocks can solidify portfolio growth for long-term investors. Discover the stocks to buy in 2024. 
Via InvestorPlace
These Were the 3 Best Dow Stocks in 2023. Can They Repeat in 2024?
The best dow stocks in 2023 all have one thing in common which is having AI help lift them and the index higher this year. 
Via InvestorPlace
Topics Artificial Intelligence Stocks
Exposures Artificial Intelligence US Equities
Will UnitedHealth Group Be a Trillion-Dollar Stock by 2030?
Ten years ago, UnitedHealth Group's stock was worth just under $75 billion. 
Via The Motley Fool
If You Invested $100 In This Stock 15 Years Ago, You Would Have $2,000 Today
Via Benzinga
UnitedHealth Group Unusual Options Activity For December 19
Via Benzinga
12 Analysts Have This to Say About UnitedHealth Group
Via Benzinga
Geriatrician and value-based-care leader John Mach, MD joins Ceresti Health as Chief Medical Officer
Via Get News
7 Blue-Chip Dividend Stocks to Buy Before Dec. 31
Always a strong investment, blue-chip dividend stocks continue to make sense as 2023 draws closer to an end and 2024 nears. 
Via InvestorPlace
3 Stocks Destined for Trillion-Dollar Glory in the Near Future
These inevitable trillion-dollar stocks are poised for glory, thriving in a robust U.S. economy with standout growth and innovation. 
Via InvestorPlace
Topics Economy
Exposures Economy
Elliott Wave Technical Analysis: UnitedHealth Group Inc. - Tuesday, Dec. 19
Looking for shorts after a clear five wave move off the top and a failed supported retest of $520. 
Via Talk Markets
Forget Tech! 7 Underrated Growth Stocks for Investors
Seize the opportunity with each of these seven top growth stocks, all of which are in industries out of the tech sector. 
Via InvestorPlace
The New Magnificent 7: 7 Stocks Rising to Prominence
The next magnificent 7 stocks continue to rise to prominence and offer strong returns to investors and are generally stable. 
Via InvestorPlace
3 Industry Stalwarts You Can Buy and Forget About
If you're a risk-averse investor, these stocks are great options for you. 
Via The Motley Fool
The Dow Jones Just Hit a Record High. History Says Stocks Will Do This Next.
The Dow Jones Industrial Average just entered bull market territory, a milestone that implies more upward momentum in the blue chip index. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
AM Best Upgrades Credit Ratings of The Chesapeake Life Insurance Company; Affirms Credit Ratings of UnitedHealth Group Incorporated and Its Subsidiaries
From AM Best
Via Business Wire
Elliott Wave Technical Analysis: UnitedHealth Group Inc.
Looking for longs after a classic trading pattern on $550. 
Via Talk Markets
3 Compelling Dividend Stocks With Strong Buy Ratings
Are you on the hunt to generate passive income in 2024? Then consider these 3 strong buy dividend stocks for the new year. 
Via InvestorPlace
Supreme Court Set to Decide Future of Mifepristone: Showdown Looms Over FDA's Endorsement
The U.S. Supreme Court is set to deliberate on the future of mifepristone, a crucial drug employed in over half of all abortions within the U.S.  
Via Benzinga
Exposures Product Safety
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
56 57 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.